Exjade Novartis - Treatment for Chronic Iron Overload Due to Blood Transfusions

Exjade is a once-daily oral iron chelator approved for the treatment of chronic iron overload due to blood transfusions in adults and children age two and older.

Posted: November 2005

Related Articles:

Exjade (deferasirox) FDA Approval History

View comments

Hide
(web4)